10 pending office actions
| App # | Title | Examiner | Art Unit | Status | Filed |
|---|---|---|---|---|---|
| 18524170 | Methods of Treating B-Cell Malignancy Using Bcl-2 Inhibitor | WHITE, DAWANNA SHAR-DAY | 1627 | Non-Final OA | Nov 30, 2023 |
| 18517894 | SALTS OF A PI3Kdelta INHIBITOR, CRYSTALLINE FORMS, METHODS OF PREPARATION, AND USES THEREFORE | HABTE, KAHSAY | 1624 | Non-Final OA | Nov 22, 2023 |
| 18497586 | EGFR Degraders and Associated Methods of Use | KENYON, JOHN S | 1625 | Non-Final OA | Oct 30, 2023 |
| 18263448 | METHODS OF TREATING CHRONIC ACTIVE ANTIBODY-MEDIATED REJECTION USING BTK INHIBITORS | SEITZ, ANTHONY JOSEPH | 1629 | Non-Final OA | Jul 28, 2023 |
| 18262236 | Methods of Cancer Treatment Using Anti-TIGIT Antibodies in Combination with Anti-PD1 Antibodies | DENT, ALANA HARRIS | 1643 | Non-Final OA | Jul 20, 2023 |
| 18261629 | KRAS G12C INHIBITORS | STOCKTON, LAURA LYNNE | 1626 | Non-Final OA | Jul 14, 2023 |
| 18322542 | USE OF A COMBINATION COMPRISING A BTK INHIBITOR FOR TREATING CANCERS | STOICA, ELLY GERALD | 1647 | Non-Final OA | May 23, 2023 |
| 18309700 | ANTI-PD1 ANTIBODIES AND THEIR USE AS THERAPEUTICS AND DIAGNOSTICS | OUSPENSKI, ILIA I | 1644 | Non-Final OA | Apr 28, 2023 |
| 18099319 | ORAL CAPSULE AND PREPARATION METHOD THEREFOR | KUCHARCZK, JED A | 1623 | Final Rejection | Jan 20, 2023 |
| 17617531 | ORAL CAPSULE AND PREPARATION METHOD THEREFOR | KUCHARCZK, JED A | 1623 | Final Rejection | Dec 08, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial